---
title: Mechanisms of Toxicity
type: content
phase: 1
status: complete
priority: high
tags: [toxicology, mechanisms, cellular-toxicity, free-radicals, protein-binding, hepatotoxicity, nephrotoxicity]
created: 2025-11-08
last_modified: 2025-11-08
---

# Mechanisms of Toxicity

## Introduction

Understanding the fundamental mechanisms by which xenobiotics (foreign substances) cause cellular and organ toxicity is essential for predicting adverse effects, developing antidotes, and managing poisonings. Toxicity occurs through various mechanisms including free radical formation, protein binding, enzyme inhibition, membrane disruption, and interference with cellular processes.

## General Principles of Toxicology

### Dose-Response Relationship

**Paracelsus**: "The dose makes the poison"

**Threshold vs. Non-Threshold**:
- **Threshold**: Safe dose below which no toxicity
- **Non-Threshold**: Any dose may cause toxicity (e.g., carcinogens, mutagens)

**LD50** (Lethal Dose 50%):
- Dose that kills 50% of test animals
- Measure of acute toxicity

**Therapeutic Index**:
- **TI = TD50/ED50** (toxic dose/effective dose)
- **Wide TI**: Safer (e.g., penicillin)
- **Narrow TI**: More dangerous (e.g., digoxin, warfarin, chemotherapy)

### Phases of Toxicity

1. **Exposure**: Route (oral, inhalation, dermal, injection)
2. **Toxicokinetics**: ADME (absorption, distribution, metabolism, excretion)
3. **Toxicodynamics**: Interaction with molecular targets
4. **Cellular/Organ Effects**: Manifestation of toxicity

---

## Cellular Mechanisms of Toxicity

### Free Radical Formation and Oxidative Stress

**Free Radicals**: Molecules with unpaired electrons (highly reactive)

**Reactive Oxygen Species (ROS)**:
- **Superoxide** (O2•−)
- **Hydrogen peroxide** (H2O2)
- **Hydroxyl radical** (•OH) - most reactive

**Sources**:
- **Normal metabolism**: Mitochondrial electron transport chain (1-2% O2 → ROS)
- **Xenobiotic metabolism**: Redox cycling
- **Inflammatory cells**: Neutrophils, macrophages (respiratory burst)

**Oxidative Damage**:
1. **Lipid peroxidation**:
   - Membrane lipids → **lipid peroxides** → **membrane dysfunction**
   - **Propagating chain reaction**
   - Example: Carbon tetrachloride (CCl4) hepatotoxicity

2. **Protein oxidation**:
   - **Protein carbonylation** → loss of function
   - Enzyme inactivation

3. **DNA oxidation**:
   - **8-hydroxyguanosine** (DNA damage marker)
   - **Mutagenesis**, carcinogenesis

4. **Mitochondrial dysfunction**:
   - **Opening of mitochondrial permeability transition pore (MPTP)**
   - **↓ATP production**
   - **Apoptosis**

**Antioxidant Defenses**:
- **Enzymatic**:
  - **Superoxide dismutase (SOD)**: O2•− → H2O2
  - **Catalase**: H2O2 → H2O + O2
  - **Glutathione peroxidase**: H2O2 → H2O (uses GSH)
  - **Glutathione reductase**: Regenerates GSH
- **Non-enzymatic**:
  - **Glutathione (GSH)**: Major cellular antioxidant
  - **Vitamin E** (α-tocopherol): Lipid-soluble, membrane protection
  - **Vitamin C** (ascorbic acid): Water-soluble
  - **β-carotene**, **uric acid**

**Example Toxins**:
- **Acetaminophen**: NAPQI (reactive metabolite) → GSH depletion → oxidative stress → hepatotoxicity
- **Paraquat**: Redox cycling → O2•− → pulmonary fibrosis
- **Doxorubicin**: ROS → cardiotoxicity

### Covalent Binding to Proteins and DNA

**Electrophilic Metabolites**: Reactive intermediates bind nucleophilic sites (proteins, DNA)

**Protein Adduct Formation**:
- **Enzyme inhibition** (loss of function)
- **Receptor dysfunction**
- **Structural protein damage**
- **Immune response** (hapten formation → hypersensitivity)

**DNA Adduct Formation**:
- **Mutagenesis** (base substitution, deletion, insertion)
- **Carcinogenesis** (oncogene activation, tumor suppressor inactivation)

**Examples**:
- **Acetaminophen**: NAPQI binds hepatic proteins → necrosis
- **Alkylating agents** (cancer drugs): DNA alkylation → therapeutic and toxic
- **Vinyl chloride**: Binds DNA → hepatic angiosarcoma

**Bioactivation**: Many toxins are **prodrugs** requiring metabolic activation

### Disruption of Calcium Homeostasis

**Normal Ca2+ Regulation**:
- **Intracellular Ca2+**: 100 nM (tightly regulated)
- **Extracellular Ca2+**: 1-2 mM
- **Ca2+ pumps** (ATPases) maintain gradient

**Ca2+ Overload**:
- **Mechanisms**:
  - ↑Ca2+ influx (channel opening)
  - ↓Ca2+ efflux (pump inhibition)
  - Ca2+ release from ER, mitochondria
- **Consequences**:
  - **Activation of proteases** (calpains) → protein degradation
  - **Activation of lipases** (phospholipases) → membrane damage
  - **Activation of endonucleases** → DNA fragmentation
  - **Mitochondrial dysfunction** → ↓ATP
  - **Apoptosis/necrosis**

**Examples**:
- **Digitalis glycosides**: Inhibit Na+/K+-ATPase → ↑intracellular Na+ → ↓Na+/Ca2+ exchange → ↑Ca2+
- **Carbon monoxide**: Hypoxia → ↓ATP → pump failure → Ca2+ overload

### Mitochondrial Dysfunction

**Mitochondrial Toxicity Mechanisms**:
1. **Inhibition of electron transport chain**:
   - **Complex I**: Rotenone, MPP+
   - **Complex III**: Antimycin A
   - **Complex IV**: Cyanide, carbon monoxide, H2S

2. **Uncoupling of oxidative phosphorylation**:
   - **Proton leak** (dissipation of gradient)
   - **↓ATP synthesis**, **↑O2 consumption**, **↑heat**
   - Examples: DNP (2,4-dinitrophenol), aspirin (high doses), fatty acids

3. **Inhibition of ATP synthase**:
   - Oligomycin

4. **Opening of MPTP**:
   - **Ca2+ overload**, **oxidative stress**, **↓ATP**
   - **Cytochrome c release** → apoptosis

**Consequences**:
- **↓ATP**: Cell death
- **↑ROS**: Oxidative damage
- **Apoptosis**: Intrinsic pathway

**Examples**:
- **Cyanide**: Inhibits cytochrome c oxidase (Complex IV) → anoxia
- **Rotenone**: Inhibits Complex I → parkinsonism
- **Valproate**: Mitochondrial β-oxidation inhibition → hepatotoxicity
- **NRTIs** (nucleoside reverse transcriptase inhibitors): Inhibit mitochondrial DNA polymerase → lactic acidosis

### Disruption of Protein Synthesis

**Mechanisms**:
- **Ribosomal inhibition**
- **tRNA inhibition**
- **mRNA disruption**

**Examples**:
- **Ricin** (castor bean): Inactivates 60S ribosomal subunit → cell death
- **Diphtheria toxin**: ADP-ribosylates elongation factor 2 → protein synthesis inhibition

### Membrane Disruption

**Mechanisms**:
1. **Lipid peroxidation** (oxidative damage)
2. **Detergent-like action** (surfactants)
3. **Pore formation** (bacterial toxins)

**Examples**:
- **Carbon tetrachloride**: Lipid peroxidation → membrane damage
- **Ethanol**: Membrane fluidization
- **Snake venoms** (phospholipases): Membrane hydrolysis

---

## Organ-Specific Toxicity

### Hepatotoxicity (Liver)

**Vulnerability**:
- **High metabolic activity** (bioactivation of toxins)
- **High blood flow** (first-pass metabolism)
- **Concentrates xenobiotics**

**Mechanisms**:
1. **Direct hepatotoxins**:
   - **Predictable, dose-dependent**
   - **Acetaminophen**: NAPQI → GSH depletion → necrosis (zone 3 - centrilobular)
   - **Carbon tetrachloride**: Free radicals → lipid peroxidation

2. **Idiosyncratic hepatotoxins**:
   - **Unpredictable, immune-mediated**
   - **Halothane**: Trifluoroacetyl-protein adducts → immune response → hepatitis
   - **Isoniazid, phenytoin**: Hypersensitivity hepatitis

3. **Cholestatic toxins**:
   - **Inhibit bile transport**
   - **Estrogens, anabolic steroids**: ↓Bile flow

4. **Steatosis** (fatty liver):
   - **Tetracycline, valproate**: Inhibit mitochondrial β-oxidation

**Patterns**:
- **Zone 3 (centrilobular)**: Acetaminophen, CCl4 (high CYP450)
- **Zone 1 (periportal)**: Phosphorus
- **Diffuse**: Viral hepatitis

### Nephrotoxicity (Kidney)

**Vulnerability**:
- **High blood flow** (25% cardiac output)
- **Concentrates toxins** (urine concentration)
- **High metabolic activity** (proximal tubule)

**Mechanisms**:
1. **Acute tubular necrosis (ATN)**:
   - **Aminoglycosides**: Accumulate in proximal tubule cells → necrosis
   - **Cisplatin**: DNA damage, oxidative stress
   - **Ethylene glycol**: Oxalate crystals → tubular obstruction

2. **Interstitial nephritis**:
   - **Immune-mediated**
   - **NSAIDs, penicillins**: Hypersensitivity

3. **Glomerular damage**:
   - **Gold, penicillamine**: Immune complex deposition

4. **Papillary necrosis**:
   - **Chronic NSAID use**, **aspirin**, **phenacetin**

5. **Obstructive nephropathy**:
   - **Crystals**: Uric acid, oxalate, sulfonamides

**Examples**:
- **Aminoglycosides**: Proximal tubule damage (nonoliguric renal failure)
- **Amphotericin B**: Distal tubule, collecting duct damage
- **Contrast dye**: ATN (especially with pre-existing renal disease, dehydration)

### Neurotoxicity (Nervous System)

**Mechanisms**:
1. **Neurotransmitter interference**:
   - **Organophosphates**: Acetylcholinesterase inhibition → cholinergic crisis
   - **Strychnine**: Glycine receptor antagonist → spastic paralysis

2. **Axonal degeneration**:
   - **Acrylamide, hexane**: Distal axonopathy

3. **Demyelination**:
   - **Lead**: Oligodendrocyte damage
   - **Hexachlorophene**: Intramyelinic edema

4. **Neurotransmitter depletion**:
   - **MPTP**: Destroys dopaminergic neurons → parkinsonism
   - **Reserpine**: Depletes monoamines

**Blood-Brain Barrier**:
- Limits entry of hydrophilic, charged compounds
- **Lipophilic compounds** cross readily (gases, organic solvents)

**Examples**:
- **Lead**: Encephalopathy (children), peripheral neuropathy (adults)
- **Mercury**: CNS toxicity (ataxia, tremor, cognitive impairment)
- **Carbon monoxide**: Hypoxic brain injury

### Pulmonary Toxicity

**Mechanisms**:
1. **Oxidative damage**:
   - **Paraquat**: Redox cycling → O2•− → ARDS, fibrosis
   - **Bleomycin**: ROS → pulmonary fibrosis

2. **Hypersensitivity**:
   - **Methotrexate**: Pneumonitis

3. **Direct cellular damage**:
   - **Phosgene**: Acylates proteins → pulmonary edema

**Vulnerability**:
- Large surface area exposed to environment
- High O2 concentration
- Metabolic activation (CYP450 in Clara cells)

### Cardiotoxicity

**Mechanisms**:
1. **Oxidative stress**:
   - **Doxorubicin**: ROS (iron-mediated) → cardiomyopathy

2. **Mitochondrial dysfunction**:
   - **Cyanide, CO**: Inhibit electron transport

3. **Ca2+ overload**:
   - **Digitalis**: Inhibit Na+/K+-ATPase

4. **Direct myocyte damage**:
   - **Ethanol**: Cardiomyopathy

5. **Arrhythmias**:
   - **Class IA/IC antiarrhythmics**: Proarrhythmic (QT prolongation)

---

## Immunotoxicity

### Hypersensitivity Reactions

**Type I** (IgE-mediated):
- **Penicillins**: Anaphylaxis

**Type II** (Cytotoxic):
- **Methyldopa**: Hemolytic anemia (anti-RBC antibodies)
- **Procainamide, hydralazine**: Drug-induced lupus

**Type III** (Immune Complex):
- **Serum sickness**: Fever, rash, arthralgia (penicillins, sulfonamides)

**Type IV** (Cell-Mediated):
- **Contact dermatitis**: Poison ivy, nickel

**Hapten Formation**:
- Small molecule binds protein → **hapten-protein complex** → immune response

### Immunosuppression

**Mechanisms**:
- **Lymphocyte depletion**: Cyclophosphamide, glucocorticoids
- **Inhibit cytokine production**: Cyclosporine, tacrolimus

**Consequences**: ↑Infection risk, ↑cancer risk

---

## Carcinogenesis

### Mechanisms

**Genotoxic Carcinogens**:
- **DNA damage** (mutations)
- **Initiation**: Mutation in critical gene (oncogene, tumor suppressor)
- Examples: Alkylating agents, polycyclic aromatic hydrocarbons, aflatoxin

**Non-Genotoxic Carcinogens**:
- **Promote tumor growth** without direct DNA damage
- **Mechanisms**: Hormonal (estrogens), chronic inflammation, immunosuppression
- Examples: Phorbol esters, hormones, asbestos

**Stages**:
1. **Initiation**: Irreversible DNA mutation
2. **Promotion**: Clonal expansion of initiated cells
3. **Progression**: Additional mutations → malignancy

**Ames Test**: Bacterial mutagenicity assay (screening for carcinogens)

---

## Developmental Toxicity (Teratogenesis)

**Critical Periods**:
- **Weeks 3-8** (organogenesis): Most susceptible to malformations
- **Before implantation**: All-or-none (death or no effect)

**Mechanisms**:
- **DNA damage**
- **Oxidative stress**
- **Interference with cell signaling**
- **Folate antagonism**

**Examples**:
- **Thalidomide**: Limb reduction defects (phocomelia)
- **Isotretinoin (vitamin A)**: Craniofacial, cardiac, CNS defects
- **Valproate**: Neural tube defects
- **ACE inhibitors**: Renal dysgenesis (2nd/3rd trimester)
- **Alcohol**: Fetal alcohol syndrome

---

## Factors Affecting Toxicity

### Age

**Neonates/Infants**:
- **Immature metabolism** (CYP450, glucuronidation)
- **Immature blood-brain barrier**
- **Increased susceptibility**: Chloramphenicol (gray baby syndrome), kernicterus (bilirubin)

**Elderly**:
- **Decreased renal/hepatic function**
- **Polypharmacy** (drug interactions)
- **Altered pharmacokinetics**

### Genetics

**Pharmacogenomics**:
- **CYP450 polymorphisms**: Slow vs. fast metabolizers
- **NAT2** (N-acetyltransferase): Slow acetylators ↑isoniazid hepatotoxicity
- **TPMT** (thiopurine methyltransferase): Deficiency → 6-MP toxicity
- **G6PD deficiency**: Hemolysis with oxidant drugs (dapsone, primaquine)

### Sex

**Differences**:
- **Body composition** (fat, water)
- **Hormonal effects** on metabolism
- **Enzyme activity** (some CYP450 isoforms)

### Nutrition

**Malnutrition**:
- **↓Protein**: ↓Drug binding, ↓metabolism
- **↓GSH**: ↑Oxidative toxicity
- **Vitamin deficiencies**: ↑Susceptibility

**Obesity**: Altered drug distribution (lipophilic drugs)

### Disease States

**Liver disease**: ↓Metabolism, ↓first-pass
**Renal disease**: ↓Excretion (accumulation)
**Heart failure**: ↓Hepatic blood flow → ↓metabolism

---

## Clinical Pearls

1. **Free radicals** cause oxidative damage (lipid peroxidation, protein oxidation, DNA damage)
2. **Glutathione** major cellular antioxidant (acetaminophen toxicity when depleted)
3. **Bioactivation** required for many toxins (prodrugs → reactive metabolites)
4. **Mitochondrial dysfunction** → ↓ATP, ↑ROS → cell death
5. **Dose-response relationship** fundamental principle (dose makes the poison)
6. **Hepatotoxicity mechanisms**: Direct (acetaminophen), idiosyncratic (halothane), cholestatic
7. **Nephrotoxicity**: Aminoglycosides (proximal tubule), NSAIDs (interstitial nephritis)
8. **Teratogenesis**: Critical period weeks 3-8 (organogenesis)
9. **Immunotoxicity**: Hypersensitivity (hapten formation), immunosuppression
10. **Individual variation**: Age, genetics, nutrition, disease affect toxicity

---

## Key Takeaways

1. **Free radical formation**: Major mechanism (lipid peroxidation, oxidative stress)
2. **Protein/DNA binding**: Covalent adducts → loss of function, mutagenesis
3. **Ca2+ overload**: Activates degradative enzymes → cell death
4. **Mitochondrial dysfunction**: ↓ATP, ↑ROS, apoptosis
5. **Glutathione (GSH)**: Essential antioxidant (depleted in acetaminophen toxicity)
6. **Organ-specific toxicity**: Liver (bioactivation), kidney (concentration), CNS (BBB)
7. **Bioactivation**: Many toxins require metabolic activation to reactive intermediates
8. **Individual factors**: Age, genetics, nutrition, disease alter susceptibility
9. **Carcinogenesis**: Genotoxic (DNA damage) vs. non-genotoxic (promotion)
10. **Teratogenesis**: Critical period organogenesis (weeks 3-8), mechanisms vary

---

## References

1. Katzung's Basic & Clinical Pharmacology, 15th Edition
2. Casarett and Doull's Toxicology: The Basic Science of Poisons, 9th Edition
3. Goodman & Gilman's Pharmacological Basis of Therapeutics, 14th Edition
4. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine, 5th Edition
5. Timbrell JA. Principles of Biochemical Toxicology, 4th Edition
